vTv Therapeutics (VTVT) Earnings Date & Reports

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

VTVT is expected to report earnings to rise 9.52% to -114 cents per share on November 05

vTv Therapeutics VTVT Stock Earnings Reports

Q3'26

Est.

$-1.15

Q2'26

Missed

by $0.15

Q1'26

Beat

by $2.71

Q3'25

Beat

by $0.42

Q2'25

Beat

by $0.20

The last earnings report on August 06 showed earnings per share of -104 cents, missing the estimate of -89 cents. With 5.15K shares outstanding, the current market capitalization sits at 120.67M.

View a ticker or compare two or three

VTVT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for VTVT